PRR11 and breast carcinoma: The rate of PRR11 amplification is 15.9% in the Metastatic Breast Cancer (MBC) project, but 9.5% and 9.4% in METABRIC and The Cancer Genome Atlas (TCGA), respectively (Fig. 2a).